References
- Straus DJ. Management of anemia in patients with hematologic malignancies. Oncology. 2006;20(8 Suppl. 6):8–11.
- Littlewood TJ. Erythropoietin for the treatment of anemia associated with hematological malignancy. Hematol Oncol. 2001;19(1):19–30.
- Coiffier B. Anemia associated with non-platinum chemotherapy (CT) for Hodgkin’s lymphoma (HL) or non-Hodgkin’s lymphoma (NHL). Eur J Cancer. 1999;35:S331.
- Ludwig H. Anemia of hematologic malignancies: what are the treatment options? Semin Oncol. 2002;29(3 Suppl. 8):45–54.
- Straus DJ. Epoetin alfa as a supportive measure in hematologic malignancies. Semin Hematol. 2002;39(4 Suppl. 3):25–31.
- Steele M, Narendran A. Mechanisms of defective erythropoiesis and anemia in pediatric acute lymphoblastic leukemia (ALL). Ann Hematol. 2012;91(10):1513–1518.
- Littlewood T, Mandelli F. The effects of anemia in hematologic malignancies: more than a symptom. Semin Oncol. 2002;29(3 Suppl. 8):40–44.
- Anderson HL, Brodsky IE, Mangalmurti NS. The evolving erythrocyte: red blood cells as modulators of innate immunity. J Immunol. 2018;201(5):1343–1351.
- Nelson RJ. The immune-adherence phenomenon; an immunologically specific reaction between microorganisms and erythrocytes leading to enhanced phagocytosis. Science. 1953;118(3077):733–737.
- Darbonne WC, Rice GC, Mohler MA, et al. Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin. J Clin Invest. 1991;88(4):1362–1369.
- Neote K, Darbonne W, Ogez J, et al. Identification of a promiscuous inflammatory peptide receptor on the surface of red blood cells. J Biol Chem. 1993;268(17):12247–12249.
- Hotz MJ, Qing D, Shashaty M, et al. Red blood cells homeostatically bind mitochondrial DNA through TLR9 to maintain quiescence and to prevent lung injury. Am J Respir Crit Care Med. 2018;197(4):470–480.
- Lam L, Murphy S, Kokkinaki D, et al. DNA binding to TLR9 expressed by red blood cells promotes innate immune activation and anemia. Sci Transl Med. 2021;13(616):j1008.
- Zhang Q, Raoof M, Chen Y, et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature. 2010;464(7285):104–107.
- Lu CH, Chang WN, Tsai NW, et al. The value of serial plasma nuclear and mitochondrial DNA levels in adult community-acquired bacterial meningitis. QJM. 2010;103(3):169–175.
- Cossarizza A, Pinti M, Nasi M, et al. Increased plasma levels of extracellular mitochondrial DNA during HIV infection: a new role for mitochondrial damage-associated molecular patterns during inflammation. Mitochondrion. 2011;11(5):750–755.
- Sursal T, Stearns-Kurosawa DJ, Itagaki K, et al. Plasma bacterial and mitochondrial DNA distinguish bacterial sepsis from sterile systemic inflammatory response syndrome and quantify inflammatory tissue injury in nonhuman primates. Shock. 2013;39(1):55–62.
- Krychtiuk KA, Ruhittel S, Hohensinner PJ, et al. Mitochondrial DNA and Toll-Like receptor-9 are associated with mortality in critically ill patients. Crit Care Med. 2015;43(12):2633–2641.
- Nakahira K, Kyung SY, Rogers AJ, et al. Circulating mitochondrial DNA in patients in the ICU as a marker of mortality: derivation and validation. PLoS Med. 2013;10(12):e1001577.
- Leimkuhler NB, Schneider RK. Inflammatory bone marrow microenvironment. Hematology Am Soc Hematol Educ Program. 2019;2019(1):294–302.
- Hunger SP, Mullighan CG. Acute lymphoblastic leukemia in children. N Engl J Med. 2015;373(16):1541–1552.
- Terpos E, Kleber M, Engelhardt M, et al. European Myeloma Network Guidelines for the management of multiple myeloma-related complications. Haematologica. 2015;100(10):1254–1266.
- Zheng G, Chen P, Pallavajjalla A, et al. The diagnostic utility of targeted gene panel sequencing in discriminating etiologies of cytopenia. Am J Hematol. 2019;94(10):1141–1148.
- Chaparro CM, Suchdev PS. Anemia epidemiology, pathophysiology, and etiology in low- and middle-income countries. Ann N Y Acad Sci. 2019;1450(1):15–31.
- Young NS. Aplastic anemia. N Engl J Med. 2018;379(17):1643–1656.
- Kordbacheh F, O'Meara CH, Coupland LA, et al. Extracellular histones induce erythrocyte fragility and anemia. Blood. 2017;130(26):2884–2888.
- Silvestre-Roig C, Braster Q, Wichapong K, et al. Externalized histone H4 orchestrates chronic inflammation by inducing lytic cell death. Nature. 2019;569(7755):236–240.
- Xu J, Zhang X, Pelayo R, et al. Extracellular histones are major mediators of death in sepsis. Nat Med. 2009;15(11):1318–1321.
- Kutcher ME, Xu J, Vilardi RF, et al. Extracellular histone release in response to traumatic injury: implications for a compensatory role of activated protein C. J Trauma Acute Care Surg. 2012;73(6):1389–1394.
- Rozmus J, Ivison S, Kariminia A, et al. Higher levels of free plasma mitochondrial DNA are associated with the onset of chronic GvHD. Bone Marrow Transplant. 2018;53(10):1263–1269.
- Simmons JD, Lee YL, Mulekar S, et al. Elevated levels of plasma mitochondrial DNA DAMPs are linked to clinical outcome in severely injured human subjects. Ann Surg. 2013;258(4):591–598.
- Lood C, Blanco LP, Purmalek MM, et al. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. Nat Med. 2016;22(2):146–153.
- Yang R, Tonnesseen TI. DAMPs and sterile inflammation in drug hepatotoxicity. Hepatol Int. 2019;13(1):42–50.
- Lu NF, Jiang L, Zhu B, et al. Elevated plasma histone H4 levels are an important risk factor in the development of septic cardiomyopathy. Balkan Med J. 2020;37(2):72–78.
- Arruda-Silva F, Bianchetto-Aguilera F, Gasperini S, et al. Human neutrophils produce CCL23 in response to various TLR-agonists and TNFalpha. Front Cell Infect Microbiol. 2017;7:176.
- Steinbach D, Schramm A, Eggert A, et al. Identification of a set of seven genes for the monitoring of minimal residual disease in pediatric acute myeloid leukemia. Clin Cancer Res. 2006;12(8):2434–2441.
- Patel VP, Kreider BL, Li Y, et al. Molecular and functional characterization of two novel human C–C chemokines as inhibitors of two distinct classes of myeloid progenitors. J Exp Med. 1997;185(7):1163–1172.
- Han IS, Ra JS, Kim MW, et al. Differentiation of CD34+ cells from human cord blood and murine bone marrow is suppressed by C6 beta-chemokines. Mol Cells. 2003;15(2):176–180.
- Noh EK, Ra JS, Lee SA, et al. CKbeta8-1 alters expression of cyclin E in colony forming units-granulocyte macrophage (CFU-GM) lineage from human cord blood CD34+ cells. Exp Mol Med. 2005;37(6):619–623.